Allarity Therapeutics, Inc. Equity, Fair Value Adjustment
Allarity Therapeutics, Inc. (ALLR) reported Equity, Fair Value Adjustment of $1.26 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:EquityFairValueAdjustment · last filed 2022-11-14
- Allarity Therapeutics, Inc. equity, fair value adjustment for the quarter ending 2022-09-30 was -$257.00K.
- Allarity Therapeutics, Inc. equity, fair value adjustment for the quarter ending 2022-06-30 was -$746.00K.
- Allarity Therapeutics, Inc. equity, fair value adjustment for the quarter ending 2022-03-31 was $2.27M.
| Period end | Equity, Fair Value Adjustment 3 month | Equity, Fair Value Adjustment 6 month | Equity, Fair Value Adjustment 9 month | Equity, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.00M derived: sum of 2 quarters · filed 2022-11-14 | $1.26M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$746.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | $1.52M 10-Q · filed 2022-10-07 | ||
| 2022-03-31 | $2.27M 10-Q · filed 2022-05-27 | |||
| 2021-12-31 | $11.27M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |